| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Common Stock | Options Exercise | $358,267 | +9,100 | +73% | $39.37 | 21,576 | 12 Nov 2021 | Direct | |
| transaction | AVNT | Common Stock | Disposed to Issuer | $411,172 | -6,949 | -32% | $59.17 | 14,627 | 12 Nov 2021 | Direct | |
| transaction | AVNT | Common Stock | Options Exercise | $297,262 | +11,900 | +81% | $24.98 | 26,527 | 12 Nov 2021 | Direct | |
| transaction | AVNT | Common Stock | Disposed to Issuer | $436,675 | -7,380 | -28% | $59.17 | 19,147 | 12 Nov 2021 | Direct | |
| holding | AVNT | Common Stock | 4,067 | 12 Nov 2021 | Supplemental Plan | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -9,100 | -100% | $0.000000* | 0 | 12 Nov 2021 | Common Stock | 9,100 | $39.37 | Direct | F2 |
| transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -11,900 | -100% | $0.000000* | 0 | 12 Nov 2021 | Common Stock | 11,900 | $24.98 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The information in this report is based on a plan statement as of November 12, 2021. |
| F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from a market value per share of $39.37 and no more than one-third of the grant can vest per year during the first three years. |
| F3 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years. |